Concepedia

Sarah Uboldi

SU

12

Publications

1.3K

Citations

11

H-Index

2010

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

PharmaMar (Spain)

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

Sarah Uboldi is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, pathology, and cell biology.

Top concepts

MedicinePathologyCell BiologyTumor MicroenvironmentImmunologyTumor BiologyCancer ResearchEngineeringCytoskeletonCancer Biology

Publications per year

2010–2017

12

Publications

12

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

Giovanni Germano, Roberta Frapolli, Cristina Belgiovine et al. · Cancer Cell · 2013 · 847 citations · Full text

Cancer Immunosurveillance, Drug Targeting, Immunology +7

Mode of action of trabectedin in myxoid liposarcomas

Silvia Di Giandomenico, Roberta Frapolli, Ezia Bello et al. · Oncogene · 2013 · 128 citations

Surgical Pathology, Histopathology, Pathology +4

Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1

Romina Dossi, Roberta Frapolli, Silvana Di Giandomenico et al. · International Journal of Cancer · 2014 · 57 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents

Ana Teresa Amaral, Cecilia Garofalo, Roberta Frapolli et al. · Clinical Cancer Research · 2015 · 43 citations · Full text

Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin

Benedetta Colmegna, Sarah Uboldi, Roberta Frapolli et al. · British Journal of Cancer · 2015 · 43 citations · Full text

Rows per page

1–5 of 12